12,131 followers
RT @FrontOncology: New research: Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an…
RT @FrontOncology: New research: Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an…
New research: Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an international Delphi consensus report: Introduction Osimertinib is recommended by major guidelines for use in the adjuvant… https://t.c